The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PEGylated Proteins Market Research Report 2024
Synopsis
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
The global PEGylated Proteins market was valued at US$ 3769 million in 2023 and is anticipated to reach US$ 4908.6 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.
This report aims to provide a comprehensive presentation of the global market for PEGylated Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEGylated Proteins.
Report Scope
The PEGylated Proteins market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PEGylated Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEGylated Proteins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
Segment by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibodies
Others
Segment by Application
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PEGylated Proteins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PEGylated Proteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
The global PEGylated Proteins market was valued at US$ 3769 million in 2023 and is anticipated to reach US$ 4908.6 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.
This report aims to provide a comprehensive presentation of the global market for PEGylated Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PEGylated Proteins.
Report Scope
The PEGylated Proteins market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PEGylated Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PEGylated Proteins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ENZON Pharmaceuticals
Merck Sharp & Dohme
Roche
Pfizer
Amgen
UCB
Crealta (Savient)
Segment by Type
Colony Stimulating Factors
Interferons
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibodies
Others
Segment by Application
Cancer Treatment
Hepatitis
Chronic Kidney Disease
Leukemia
SCID
Rheumatoid Arthritis & Crohn's Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PEGylated Proteins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PEGylated Proteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 PEGylated Proteins Market Overview
1.1 Product Overview and Scope of PEGylated Proteins
1.2 PEGylated Proteins Segment by Type
1.2.1 Global PEGylated Proteins Market Value Comparison by Type (2024-2030)
1.2.2 Colony Stimulating Factors
1.2.3 Interferons
1.2.4 Erythropoietin (EPO)
1.2.5 Recombinant Factor VIII
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 PEGylated Proteins Segment by Application
1.3.1 Global PEGylated Proteins Market Value by Application: (2024-2030)
1.3.2 Cancer Treatment
1.3.3 Hepatitis
1.3.4 Chronic Kidney Disease
1.3.5 Leukemia
1.3.6 SCID
1.3.7 Rheumatoid Arthritis & Crohn's Disease
1.3.8 Others
1.4 Global PEGylated Proteins Market Size Estimates and Forecasts
1.4.1 Global PEGylated Proteins Revenue 2019-2030
1.4.2 Global PEGylated Proteins Sales 2019-2030
1.4.3 Global PEGylated Proteins Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 PEGylated Proteins Market Competition by Manufacturers
2.1 Global PEGylated Proteins Sales Market Share by Manufacturers (2019-2024)
2.2 Global PEGylated Proteins Revenue Market Share by Manufacturers (2019-2024)
2.3 Global PEGylated Proteins Average Price by Manufacturers (2019-2024)
2.4 Global PEGylated Proteins Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PEGylated Proteins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PEGylated Proteins, Product Type & Application
2.7 PEGylated Proteins Market Competitive Situation and Trends
2.7.1 PEGylated Proteins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PEGylated Proteins Players Market Share by Revenue
2.7.3 Global PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PEGylated Proteins Retrospective Market Scenario by Region
3.1 Global PEGylated Proteins Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global PEGylated Proteins Global PEGylated Proteins Sales by Region: 2019-2030
3.2.1 Global PEGylated Proteins Sales by Region: 2019-2024
3.2.2 Global PEGylated Proteins Sales by Region: 2025-2030
3.3 Global PEGylated Proteins Global PEGylated Proteins Revenue by Region: 2019-2030
3.3.1 Global PEGylated Proteins Revenue by Region: 2019-2024
3.3.2 Global PEGylated Proteins Revenue by Region: 2025-2030
3.4 North America PEGylated Proteins Market Facts & Figures by Country
3.4.1 North America PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America PEGylated Proteins Sales by Country (2019-2030)
3.4.3 North America PEGylated Proteins Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PEGylated Proteins Market Facts & Figures by Country
3.5.1 Europe PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe PEGylated Proteins Sales by Country (2019-2030)
3.5.3 Europe PEGylated Proteins Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PEGylated Proteins Market Facts & Figures by Country
3.6.1 Asia Pacific PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific PEGylated Proteins Sales by Country (2019-2030)
3.6.3 Asia Pacific PEGylated Proteins Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PEGylated Proteins Market Facts & Figures by Country
3.7.1 Latin America PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America PEGylated Proteins Sales by Country (2019-2030)
3.7.3 Latin America PEGylated Proteins Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PEGylated Proteins Market Facts & Figures by Country
3.8.1 Middle East and Africa PEGylated Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa PEGylated Proteins Sales by Country (2019-2030)
3.8.3 Middle East and Africa PEGylated Proteins Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PEGylated Proteins Sales by Type (2019-2030)
4.1.1 Global PEGylated Proteins Sales by Type (2019-2024)
4.1.2 Global PEGylated Proteins Sales by Type (2025-2030)
4.1.3 Global PEGylated Proteins Sales Market Share by Type (2019-2030)
4.2 Global PEGylated Proteins Revenue by Type (2019-2030)
4.2.1 Global PEGylated Proteins Revenue by Type (2019-2024)
4.2.2 Global PEGylated Proteins Revenue by Type (2025-2030)
4.2.3 Global PEGylated Proteins Revenue Market Share by Type (2019-2030)
4.3 Global PEGylated Proteins Price by Type (2019-2030)
5 Segment by Application
5.1 Global PEGylated Proteins Sales by Application (2019-2030)
5.1.1 Global PEGylated Proteins Sales by Application (2019-2024)
5.1.2 Global PEGylated Proteins Sales by Application (2025-2030)
5.1.3 Global PEGylated Proteins Sales Market Share by Application (2019-2030)
5.2 Global PEGylated Proteins Revenue by Application (2019-2030)
5.2.1 Global PEGylated Proteins Revenue by Application (2019-2024)
5.2.2 Global PEGylated Proteins Revenue by Application (2025-2030)
5.2.3 Global PEGylated Proteins Revenue Market Share by Application (2019-2030)
5.3 Global PEGylated Proteins Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ENZON Pharmaceuticals
6.1.1 ENZON Pharmaceuticals Corporation Information
6.1.2 ENZON Pharmaceuticals Description and Business Overview
6.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ENZON Pharmaceuticals PEGylated Proteins Product Portfolio
6.1.5 ENZON Pharmaceuticals Recent Developments/Updates
6.2 Merck Sharp & Dohme
6.2.1 Merck Sharp & Dohme Corporation Information
6.2.2 Merck Sharp & Dohme Description and Business Overview
6.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Sharp & Dohme PEGylated Proteins Product Portfolio
6.2.5 Merck Sharp & Dohme Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche PEGylated Proteins Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer PEGylated Proteins Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen PEGylated Proteins Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 UCB
6.6.1 UCB Corporation Information
6.6.2 UCB Description and Business Overview
6.6.3 UCB PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.6.4 UCB PEGylated Proteins Product Portfolio
6.6.5 UCB Recent Developments/Updates
6.7 Crealta (Savient)
6.6.1 Crealta (Savient) Corporation Information
6.6.2 Crealta (Savient) Description and Business Overview
6.6.3 Crealta (Savient) PEGylated Proteins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Crealta (Savient) PEGylated Proteins Product Portfolio
6.7.5 Crealta (Savient) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PEGylated Proteins Industry Chain Analysis
7.2 PEGylated Proteins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PEGylated Proteins Production Mode & Process
7.4 PEGylated Proteins Sales and Marketing
7.4.1 PEGylated Proteins Sales Channels
7.4.2 PEGylated Proteins Distributors
7.5 PEGylated Proteins Customers
8 PEGylated Proteins Market Dynamics
8.1 PEGylated Proteins Industry Trends
8.2 PEGylated Proteins Market Drivers
8.3 PEGylated Proteins Market Challenges
8.4 PEGylated Proteins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
